Modeling continuous levels of resistance to multidrug therapy in cancer
From MaRDI portal
Publication:2307049
DOI10.1016/j.apm.2018.07.025zbMath1480.92102arXiv1806.07557OpenAlexW2963461654WikidataQ129502638 ScholiaQ129502638MaRDI QIDQ2307049
Publication date: 27 March 2020
Published in: Applied Mathematical Modelling (Search for Journal in Brave)
Full work available at URL: https://arxiv.org/abs/1806.07557
Related Items (3)
Theoretical modeling of collaterally sensitive drug cycles: shaping heterogeneity to allow adaptive therapy ⋮ Опухолевый рост и возможности математического моделирования системных процессов ⋮ The impact of competition between cancer cells and healthy cells on optimal drug delivery
Cites Work
- Unnamed Item
- Transfer of drug resistance characteristics between cancer cell subpopulations: a study using simple mathematical models
- Analysis of tracer particle migration in inhomogeneous turbulence
- A model for the resistance of tumor cells to cancer chemotherapeutic agents
- An introduction to copulas. Properties and applications
- Continuous and discrete mathematical models of tumor-induced angiogenesis
- A mathematical model of drug resistance: Heterogeneous tumors
- Modeling the dynamics of heterogeneity of solid tumors in response to chemotherapy
- Evolution of resistance to anti-cancer therapy during general dosing schedules
- Modeling the chemotherapy-induced selection of drug-resistant traits during tumor growth
- An elementary approach to modeling drug resistance in cancer
- Stochastic modeling of drug resistance in cancer
- The impact of cell density and mutations in a model of multidrug resistance in solid tumors
- Modeling the effects of space structure and combination therapies on phenotypic heterogeneity and drug resistance in solid tumors
- Populational adaptive evolution, chemotherapeutic resistance and multiple anti-cancer therapies
- Mathematical Models of Avascular Tumor Growth
- A hybrid mathematical model of solid tumour invasion: the importance of cell adhesion
This page was built for publication: Modeling continuous levels of resistance to multidrug therapy in cancer
